fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Smokers and COPD patients suffer more and die more from COVID-19

Written by | 29 Jul 2020

Article written by Bruce Sylvester. Current smokers and those with chronic obstructive pulmonary disease COPD suffer greater COVID-19 severity and greater COVID-19 related mortality..

Results from phase III DAPA-CKD trial of Farxiga met primary and secondary endpoints to treat chronic kidney disease – AstraZeneca.

Written by | 29 Jul 2020

AstraZeneca announced high-level results from Farxiga’s (dapagliflozin) Phase III DAPA-CKD trial showed a statistically significant and clinically meaningful effect on its primary endpoint of a composite of worsening… read more.

Pfizer and BioNTech choose lead mRNA vaccine candidate against COVID-19 and commence pivotal phase II/III global study.

Written by | 29 Jul 2020

Pfizer Inc. and BioNTech SE announced the start of a global (except for China) Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA… read more.

Phase III AD Up trial of Rinvoq meets endpoints in atopic dermatitis.- AbbVie

Written by | 29 Jul 2020

AbbVie announced Rinvoq (upadacitinib 15 mg and 30 mg, once daily) plus topical corticosteroids (TCS) met the co-primary endpoints and all secondary endpoints in AD Up, the third… read more.

Phase III REFALS trial of Simdax fails to meet endpoints in amyotrophic lateral sclerosis.- Orion

Written by | 29 Jul 2020

Orion’s phase III REFALS trial evaluating the efficacy of oral Simdax (levosimendan) in treatment of amyotrophic lateral sclerosis (ALS) patients did not reach its pre-specified endpoints. Orion has… read more.

Health Canada approves Velkury to treat pneumonia associated with COVID-19. -Gilead Sciences

Written by | 29 Jul 2020

Health Canada has approved, with conditions, remdesivir (Velkury) from Gilead Sciences to treat COVID-19 patients. Remdesivir is used to treat those with pneumonia who need extra oxygen to… read more.

FDA approves topical Wynzora Cream to treat plaque psoriasis.- MC2 Therapeutics

Written by | 29 Jul 2020

MC2 Therapeutics, announced that the FDA has approved Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.